SG Americas Securities’s RayzeBio, Inc. Common Stock RYZB Stock Holding History

SG Americas Securities’s Portfolio RYZB Stock Details RYZB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-8,138	Closed	-$506K	–	3584
2023 Q4	$506K	Buy	+8,138	New	+$202K	﹤0.01%	1471

SG Americas Securities's RYZB Position: Q1 2024 in Review

SG Americas Securities sold out of RayzeBio, Inc. Common Stock (RYZB) in Q1 2024, closing a stake of 8,138 shares — an estimated $506K sold.

SG Americas Securities first reported a position in RYZB in Q4 2023 and held it in 1 quarter. The position peaked at $506K in Q4 2023. 0 funds tracked by Wall St. Rank hold RYZB as of Q1 2024.

SG Americas Securities reported no remaining RayzeBio, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
SG Americas Securities sold 8,138 RayzeBio, Inc. Common Stock shares in Q1 2024, an estimated $506K.
SG Americas Securities first reported a position in RayzeBio, Inc. Common Stock in Q4 2023 and held it in 1 quarter.
SG Americas Securities's RayzeBio, Inc. Common Stock position peaked at $506K in Q4 2023.
0 funds tracked by Wall St. Rank held RayzeBio, Inc. Common Stock as of Q1 2024.

Based on SG Americas Securities's 13F filing for Q1 2024, filed 6 May 2024.